Croatia Pharmaceuticals & Healthcare Q2 2020

Croatia Pharmaceuticals & Healthcare Q2 2020

Key View:

Growth in the Croatian pharmaceutical market will accelerate slightly 2020, boosted by lower costs of non-prescriptionmedicine following VAT reductions on OTC products in 2019. In the coming years, we expect all segments of the market to graduallyslow, impeded by constrained government expenditure on healthcare. The rising cost of healthcare as the population ages will seethe government maintain a focus on cost containment measures, limiting the market’s potential over the long term.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central & Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Jadran Galenski Laboratorij
PLIVA (Teva Pharmaceuticals)
Croatia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook